These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 7080591

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Generalization of palmoplantar pustulosis after withdrawal of etretinate.
    Miyagawa S, Muramatsu T, Shirai T.
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):305-6. PubMed ID: 2007689
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment with an oral aromatic retinoid in linear porokeratosis.
    Pehamberger H, Konrad K.
    Dermatologica; 1980 Feb; 160(4):270-4. PubMed ID: 7358191
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
    Mahrle G, Meyer-Hamme S, Ippen H.
    Arch Dermatol; 1982 Feb; 118(2):97-100. PubMed ID: 7059226
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Side effects of oral retinoid Ro 10-9359 on the unaffected skin of psoriatic patients: retinoid dermatitis].
    Rüst O, Tufli T.
    Schweiz Med Wochenschr; 1979 Dec 15; 109(48):1921-5. PubMed ID: 161414
    [Abstract] [Full Text] [Related]

  • 11. Keratodermia palmoplantare papuloverrucoides progressiva: successful treatment with etretinate.
    Baran R, Juhlin L.
    J Am Acad Dermatol; 1983 May 15; 8(5):700-2. PubMed ID: 6223052
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Comparison of RePUVA and aromatic retinoid Ro 10-9359 with methotrexate in severe forms of psoriasis].
    Mashkilleysson AL, Mashkilleysson NA.
    Hautarzt; 1983 May 15; 34(5):229-30. PubMed ID: 6862887
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Low-dose etretinate in the maintenance of remission of palmoplantar pustular psoriasis.
    White SI, Puttick L, Marks JM.
    Br J Dermatol; 1986 Nov 15; 115(5):577-82. PubMed ID: 3539171
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Two years' experience with Tigason treatment of pustulosis palmo-plantaris and eczema keratoticum manuum.
    Reymann F.
    Dermatologica; 1982 Mar 15; 164(3):209-16. PubMed ID: 6211380
    [No Abstract] [Full Text] [Related]

  • 19. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J.
    Acta Derm Venereol Suppl (Stockh); 1982 Mar 15; 101():1-29. PubMed ID: 6954822
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.